In Re Neurontin Marketing and Sales Practices

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• concluding that the scholarly article regarding efficacy of pharmaceutical manufacturers’ prescription anticonvulsant drug for off-label uses was not likely to change result of trial
• holding a new meta-analysis of existing scientific studies was not new evidence because the defendant “could have performed a similar meta-analysis prior to the trial”

Source: CourtListener parenthetical corpus (CC0).